WO2009123206A1 - Composition pharmaceutique à administration per os - Google Patents
Composition pharmaceutique à administration per os Download PDFInfo
- Publication number
- WO2009123206A1 WO2009123206A1 PCT/JP2009/056701 JP2009056701W WO2009123206A1 WO 2009123206 A1 WO2009123206 A1 WO 2009123206A1 JP 2009056701 W JP2009056701 W JP 2009056701W WO 2009123206 A1 WO2009123206 A1 WO 2009123206A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- inflammatory
- oral pharmaceutical
- acid
- analgesic
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Definitions
- the present invention relates to an oral pharmaceutical composition. More specifically, the present invention relates to an oral pharmaceutical composition comprising a phenylpropionic acid-based anti-inflammatory analgesic as an active ingredient, wherein the gastric mucosal damage caused by the anti-inflammatory analgesic is reduced and the sustainability is improved. Furthermore, the present invention relates to a method for reducing gastric mucosal damage caused by phenylpropionic acid anti-inflammatory analgesics.
- the oral pharmaceutical composition of the present invention can be preferably used for the purpose of suppressing inflammation.
- the active ingredient phenylpropionic anti-inflammatory analgesic preferably ibuprofen
- the detoxification, analgesic and anti-inflammatory action of the component (a) is adversely affected by using three components together.
- the proportion of the component (c) to 100 parts by weight of the component (a) can be appropriately selected from the range of usually 5 to 1200 parts by weight. The range is preferably 10 to 1000 parts by weight, more preferably 16 to 667 parts by weight.
- ibuprofen which is a phenylpropionic acid anti-inflammatory analgesic
- tranexamic acid and dry aluminum hydroxide gel can prevent side effects such as gastric mucosal damage possessed by ibuprofen.
- Example 2 a graph comparing the edema rate (%) over time after carrageenin inoculation for the test substance administration group (Example 1, Comparative Examples 1, 3, 9 to 10) and the non-treatment group is shown.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composition pharmaceutique à administration per os contenant un agent anti-inflammatoire analgésique de type acide phényl-propionique, dans laquelle l'attaque de la muqueuse gastrique par l'agent analgésique est réduite. L'invention concerne également un composition pharmaceutique à administration per os contenant un agent anti-inflammatoire analgésique de type acide phénilproprionique dans laquelle ledit agent inflammatoire agit pendant un laps de temps prolongé. Plus précisément, l'invention concerne une préparation pharmaceutique à administration per os comprenant (a) un agent anti-inflammatoire analgésique de type acide phénilproprionique, (b) un acide tranexamique et (c) un gel d'hydroxyde d'aluminium séché.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008-094331 | 2008-03-31 | ||
JP2008094331A JP5542309B2 (ja) | 2008-03-31 | 2008-03-31 | 経口医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009123206A1 true WO2009123206A1 (fr) | 2009-10-08 |
Family
ID=41135574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/056701 WO2009123206A1 (fr) | 2008-03-31 | 2009-03-31 | Composition pharmaceutique à administration per os |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5542309B2 (fr) |
WO (1) | WO2009123206A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020100611A (ja) * | 2018-12-25 | 2020-07-02 | 小林製薬株式会社 | 内服用医薬組成物 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5828609B2 (ja) * | 2008-03-31 | 2015-12-09 | 小林製薬株式会社 | 持続性解熱鎮痛消炎剤 |
JP5835865B2 (ja) * | 2008-09-04 | 2015-12-24 | 興和株式会社 | ロキソプロフェン含有医薬組成物 |
JP5740896B2 (ja) * | 2009-10-27 | 2015-07-01 | ライオン株式会社 | 解熱鎮痛組成物 |
JP5844976B2 (ja) * | 2010-01-29 | 2016-01-20 | 興和株式会社 | ロキソプロフェン又はその塩を含有する医薬組成物 |
JP2011246441A (ja) * | 2010-03-31 | 2011-12-08 | Kowa Co | ロキソプロフェン又はその塩を含有する医薬組成物 |
JP6206069B2 (ja) * | 2012-10-19 | 2017-10-04 | 大正製薬株式会社 | 固形製剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0841076A (ja) * | 1993-07-26 | 1996-02-13 | Fuji Chem Ind Co Ltd | 乾燥水酸化アルミニウムゲル及びその製法並びに制酸剤 |
JPH0948728A (ja) * | 1995-03-27 | 1997-02-18 | Shiseido Co Ltd | 解熱鎮痛剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2704721B2 (ja) * | 1987-02-12 | 1998-01-26 | ライオン株式会社 | イブプロフエン製剤 |
JP3170855B2 (ja) * | 1992-03-03 | 2001-05-28 | ライオン株式会社 | イブプロフェン含有解熱鎮痛剤 |
JP2894955B2 (ja) * | 1994-07-25 | 1999-05-24 | ロート製薬株式会社 | イブプロフェン製剤 |
JPH09124493A (ja) * | 1995-11-02 | 1997-05-13 | Fuji Chem Ind Co Ltd | 制酸剤及びその製法 |
JP4947609B2 (ja) * | 2003-01-29 | 2012-06-06 | 大正製薬株式会社 | 解熱鎮痛用組成物 |
-
2008
- 2008-03-31 JP JP2008094331A patent/JP5542309B2/ja active Active
-
2009
- 2009-03-31 WO PCT/JP2009/056701 patent/WO2009123206A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0841076A (ja) * | 1993-07-26 | 1996-02-13 | Fuji Chem Ind Co Ltd | 乾燥水酸化アルミニウムゲル及びその製法並びに制酸剤 |
JPH0948728A (ja) * | 1995-03-27 | 1997-02-18 | Shiseido Co Ltd | 解熱鎮痛剤 |
Non-Patent Citations (1)
Title |
---|
PAROJCIC J. ET AL.: "Rationale for ibuprofen co-administration with antacids: Potential interaction mechanisms affecting drug absorption", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 69, no. 2, 10 January 2008 (2008-01-10), pages 640 - 647 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020100611A (ja) * | 2018-12-25 | 2020-07-02 | 小林製薬株式会社 | 内服用医薬組成物 |
JP7229013B2 (ja) | 2018-12-25 | 2023-02-27 | 小林製薬株式会社 | 内服用医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP2009242365A (ja) | 2009-10-22 |
JP5542309B2 (ja) | 2014-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6139743B2 (ja) | ロキソプロフェン含有医薬組成物 | |
JP5542309B2 (ja) | 経口医薬組成物 | |
JP5828609B2 (ja) | 持続性解熱鎮痛消炎剤 | |
JP2008500288A (ja) | 経口治療用化合物の供給系 | |
BRPI0709057A2 (pt) | veìculo mucoso bioadesivo de lenta liberação, método para preparar um veìculo mucoso bioadesivo de lenta liberação, e, uso do véiculo mucoso bioadesivo de lenta liberação | |
WO2008099397A2 (fr) | Compositions et méthodes permettant d'améliorer l'administration transmuqueuse | |
JP5403935B2 (ja) | 経口用の慢性疼痛予防または治療剤 | |
JP6192751B2 (ja) | ロキソプロフェン含有経口用組成物5 | |
JP2006001920A (ja) | 医薬製剤 | |
JP5161472B2 (ja) | 鎮痛用組成物 | |
WO2015157729A1 (fr) | Formulations pharmaceutiques comprenant un agent analgésique, un agent anti-inflammatoire non stéroïdien, un agent de suppression de la production d'acide gastrique et un antiémétique | |
JP6781561B2 (ja) | プロピオン酸系非ステロイド性消炎鎮痛薬を含有した医薬組成物 | |
US20180125792A1 (en) | Non-steroidal anti-inflammatory drugs for cough | |
JP4601595B2 (ja) | 消炎鎮痛用経口医薬組成物 | |
JPH11510168A (ja) | 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法 | |
JP5959393B2 (ja) | フェニルプロピオン酸系消炎鎮痛薬を含有する医薬組成物 | |
JP5232520B2 (ja) | ロキソプロフェンを含有する抗アデノウイルス剤 | |
JP2017132819A (ja) | ロキソプロフェン又はその塩含有の医薬組成物 | |
JPH083066A (ja) | かぜ薬製剤 | |
JP2001247481A (ja) | 医薬組成物 | |
JP7119650B2 (ja) | 鎮痛剤 | |
JP7026457B2 (ja) | ロキソプロフェン又はその塩及びビタミンb12類を含有する経口用医薬組成物 | |
JPWO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
JP2021004263A (ja) | プロピオン酸系非ステロイド性消炎鎮痛薬を含有した医薬組成物 | |
JP2014162771A (ja) | 医薬品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09726470 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09726470 Country of ref document: EP Kind code of ref document: A1 |